nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Temozolomide—skin cancer	0.307	0.556	CiPCiCtD
Carmustine—melanoma—skin cancer	0.296	1	CtDrD
Carmustine—Alkylating Activity—Dacarbazine—skin cancer	0.245	0.444	CiPCiCtD
Carmustine—CYP1A2—Imiquimod—skin cancer	0.0444	0.452	CbGbCtD
Carmustine—CYP1A2—Vemurafenib—skin cancer	0.0243	0.247	CbGbCtD
Carmustine—CYP1A2—Dacarbazine—skin cancer	0.0186	0.19	CbGbCtD
Carmustine—CYP1A2—Fluorouracil—skin cancer	0.0109	0.111	CbGbCtD
Carmustine—Haemorrhage—Bleomycin—skin cancer	9.2e-05	0.00173	CcSEcCtD
Carmustine—Hypoaesthesia—Bleomycin—skin cancer	9.15e-05	0.00172	CcSEcCtD
Carmustine—Infection—Imiquimod—skin cancer	9.14e-05	0.00172	CcSEcCtD
Carmustine—Muscular weakness—Fluorouracil—skin cancer	9.12e-05	0.00172	CcSEcCtD
Carmustine—Neutropenia—Temozolomide—skin cancer	9.07e-05	0.00171	CcSEcCtD
Carmustine—Tachycardia—Imiquimod—skin cancer	8.98e-05	0.00169	CcSEcCtD
Carmustine—Dysphagia—Fluorouracil—skin cancer	8.93e-05	0.00168	CcSEcCtD
Carmustine—Sepsis—Docetaxel—skin cancer	8.92e-05	0.00168	CcSEcCtD
Carmustine—Anorexia—Imiquimod—skin cancer	8.77e-05	0.00165	CcSEcCtD
Carmustine—Hyperglycaemia—Temozolomide—skin cancer	8.75e-05	0.00165	CcSEcCtD
Carmustine—Pneumonia—Temozolomide—skin cancer	8.7e-05	0.00164	CcSEcCtD
Carmustine—Phlebitis—Docetaxel—skin cancer	8.66e-05	0.00163	CcSEcCtD
Carmustine—Depression—Temozolomide—skin cancer	8.62e-05	0.00162	CcSEcCtD
Carmustine—Thrombophlebitis—Docetaxel—skin cancer	8.62e-05	0.00162	CcSEcCtD
Carmustine—Flushing—Bleomycin—skin cancer	8.54e-05	0.00161	CcSEcCtD
Carmustine—Body temperature increased—Vemurafenib—skin cancer	8.53e-05	0.00161	CcSEcCtD
Carmustine—Pancytopenia—Fluorouracil—skin cancer	8.48e-05	0.0016	CcSEcCtD
Carmustine—Neuropathy peripheral—Temozolomide—skin cancer	8.47e-05	0.0016	CcSEcCtD
Carmustine—Swelling—Docetaxel—skin cancer	8.46e-05	0.00159	CcSEcCtD
Carmustine—Stomatitis—Temozolomide—skin cancer	8.43e-05	0.00159	CcSEcCtD
Carmustine—Urinary tract infection—Temozolomide—skin cancer	8.4e-05	0.00158	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Imiquimod—skin cancer	8.38e-05	0.00158	CcSEcCtD
Carmustine—Insomnia—Imiquimod—skin cancer	8.32e-05	0.00157	CcSEcCtD
Carmustine—Paraesthesia—Imiquimod—skin cancer	8.26e-05	0.00156	CcSEcCtD
Carmustine—Dyspnoea—Imiquimod—skin cancer	8.2e-05	0.00155	CcSEcCtD
Carmustine—Somnolence—Imiquimod—skin cancer	8.18e-05	0.00154	CcSEcCtD
Carmustine—Alopecia—Bleomycin—skin cancer	8.13e-05	0.00153	CcSEcCtD
Carmustine—Pneumonia—Fluorouracil—skin cancer	8.01e-05	0.00151	CcSEcCtD
Carmustine—Erythema—Bleomycin—skin cancer	8.01e-05	0.00151	CcSEcCtD
Carmustine—Decreased appetite—Imiquimod—skin cancer	8e-05	0.00151	CcSEcCtD
Carmustine—Flushing—Dactinomycin—skin cancer	7.96e-05	0.0015	CcSEcCtD
Carmustine—Hypersensitivity—Vemurafenib—skin cancer	7.95e-05	0.0015	CcSEcCtD
Carmustine—Gastrointestinal disorder—Imiquimod—skin cancer	7.94e-05	0.0015	CcSEcCtD
Carmustine—Pain—Imiquimod—skin cancer	7.87e-05	0.00148	CcSEcCtD
Carmustine—Neuropathy peripheral—Fluorouracil—skin cancer	7.81e-05	0.00147	CcSEcCtD
Carmustine—Haemoglobin—Temozolomide—skin cancer	7.8e-05	0.00147	CcSEcCtD
Carmustine—Stomatitis—Fluorouracil—skin cancer	7.76e-05	0.00146	CcSEcCtD
Carmustine—Haemorrhage—Temozolomide—skin cancer	7.76e-05	0.00146	CcSEcCtD
Carmustine—Urinary tract infection—Fluorouracil—skin cancer	7.74e-05	0.00146	CcSEcCtD
Carmustine—Asthenia—Vemurafenib—skin cancer	7.74e-05	0.00146	CcSEcCtD
Carmustine—Hallucination—Temozolomide—skin cancer	7.72e-05	0.00145	CcSEcCtD
Carmustine—Hypoaesthesia—Temozolomide—skin cancer	7.72e-05	0.00145	CcSEcCtD
Carmustine—Oedema peripheral—Temozolomide—skin cancer	7.65e-05	0.00144	CcSEcCtD
Carmustine—Connective tissue disorder—Temozolomide—skin cancer	7.63e-05	0.00144	CcSEcCtD
Carmustine—Alopecia—Dactinomycin—skin cancer	7.58e-05	0.00143	CcSEcCtD
Carmustine—Feeling abnormal—Imiquimod—skin cancer	7.58e-05	0.00143	CcSEcCtD
Carmustine—Gastrointestinal pain—Imiquimod—skin cancer	7.52e-05	0.00142	CcSEcCtD
Carmustine—Hyponatraemia—Docetaxel—skin cancer	7.49e-05	0.00141	CcSEcCtD
Carmustine—Visual impairment—Temozolomide—skin cancer	7.48e-05	0.00141	CcSEcCtD
Carmustine—Erythema—Dactinomycin—skin cancer	7.47e-05	0.00141	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	7.46e-05	0.00141	CcSEcCtD
Carmustine—Anaemia—Bleomycin—skin cancer	7.4e-05	0.00139	CcSEcCtD
Carmustine—Diarrhoea—Vemurafenib—skin cancer	7.38e-05	0.00139	CcSEcCtD
Carmustine—Body temperature increased—Imiquimod—skin cancer	7.27e-05	0.00137	CcSEcCtD
Carmustine—Abdominal pain—Imiquimod—skin cancer	7.27e-05	0.00137	CcSEcCtD
Carmustine—Eye disorder—Temozolomide—skin cancer	7.25e-05	0.00137	CcSEcCtD
Carmustine—Flushing—Temozolomide—skin cancer	7.2e-05	0.00136	CcSEcCtD
Carmustine—Haemoglobin—Fluorouracil—skin cancer	7.19e-05	0.00135	CcSEcCtD
Carmustine—Leukopenia—Bleomycin—skin cancer	7.17e-05	0.00135	CcSEcCtD
Carmustine—Haemorrhage—Fluorouracil—skin cancer	7.15e-05	0.00135	CcSEcCtD
Carmustine—Dizziness—Vemurafenib—skin cancer	7.13e-05	0.00134	CcSEcCtD
Carmustine—Hypoaesthesia—Fluorouracil—skin cancer	7.12e-05	0.00134	CcSEcCtD
Carmustine—Ataxia—Docetaxel—skin cancer	7.02e-05	0.00132	CcSEcCtD
Carmustine—Anaemia—Dactinomycin—skin cancer	6.9e-05	0.0013	CcSEcCtD
Carmustine—Liver function test abnormal—Docetaxel—skin cancer	6.89e-05	0.0013	CcSEcCtD
Carmustine—Vomiting—Vemurafenib—skin cancer	6.86e-05	0.00129	CcSEcCtD
Carmustine—Alopecia—Temozolomide—skin cancer	6.86e-05	0.00129	CcSEcCtD
Carmustine—Chest pain—Bleomycin—skin cancer	6.82e-05	0.00128	CcSEcCtD
Carmustine—Myalgia—Bleomycin—skin cancer	6.82e-05	0.00128	CcSEcCtD
Carmustine—Rash—Vemurafenib—skin cancer	6.8e-05	0.00128	CcSEcCtD
Carmustine—Mental disorder—Temozolomide—skin cancer	6.8e-05	0.00128	CcSEcCtD
Carmustine—Dermatitis—Vemurafenib—skin cancer	6.8e-05	0.00128	CcSEcCtD
Carmustine—Hypersensitivity—Imiquimod—skin cancer	6.78e-05	0.00128	CcSEcCtD
Carmustine—Headache—Vemurafenib—skin cancer	6.76e-05	0.00127	CcSEcCtD
Carmustine—Erythema—Temozolomide—skin cancer	6.76e-05	0.00127	CcSEcCtD
Carmustine—Malnutrition—Temozolomide—skin cancer	6.76e-05	0.00127	CcSEcCtD
Carmustine—Leukopenia—Dactinomycin—skin cancer	6.69e-05	0.00126	CcSEcCtD
Carmustine—Asthenia—Imiquimod—skin cancer	6.6e-05	0.00124	CcSEcCtD
Carmustine—Confusional state—Bleomycin—skin cancer	6.59e-05	0.00124	CcSEcCtD
Carmustine—Oedema—Bleomycin—skin cancer	6.54e-05	0.00123	CcSEcCtD
Carmustine—Back pain—Temozolomide—skin cancer	6.54e-05	0.00123	CcSEcCtD
Carmustine—Infection—Bleomycin—skin cancer	6.49e-05	0.00122	CcSEcCtD
Carmustine—Dysphagia—Docetaxel—skin cancer	6.45e-05	0.00121	CcSEcCtD
Carmustine—Nausea—Vemurafenib—skin cancer	6.41e-05	0.00121	CcSEcCtD
Carmustine—Thrombocytopenia—Bleomycin—skin cancer	6.4e-05	0.00121	CcSEcCtD
Carmustine—Arrhythmia—Fluorouracil—skin cancer	6.39e-05	0.0012	CcSEcCtD
Carmustine—Vision blurred—Temozolomide—skin cancer	6.37e-05	0.0012	CcSEcCtD
Carmustine—Myalgia—Dactinomycin—skin cancer	6.36e-05	0.0012	CcSEcCtD
Carmustine—Tremor—Temozolomide—skin cancer	6.33e-05	0.00119	CcSEcCtD
Carmustine—Alopecia—Fluorouracil—skin cancer	6.32e-05	0.00119	CcSEcCtD
Carmustine—Diarrhoea—Imiquimod—skin cancer	6.3e-05	0.00119	CcSEcCtD
Carmustine—Anaemia—Temozolomide—skin cancer	6.24e-05	0.00118	CcSEcCtD
Carmustine—Anorexia—Bleomycin—skin cancer	6.23e-05	0.00117	CcSEcCtD
Carmustine—Erythema—Fluorouracil—skin cancer	6.23e-05	0.00117	CcSEcCtD
Carmustine—Agitation—Temozolomide—skin cancer	6.21e-05	0.00117	CcSEcCtD
Carmustine—Pancytopenia—Docetaxel—skin cancer	6.12e-05	0.00115	CcSEcCtD
Carmustine—Hypotension—Bleomycin—skin cancer	6.11e-05	0.00115	CcSEcCtD
Carmustine—Oedema—Dactinomycin—skin cancer	6.1e-05	0.00115	CcSEcCtD
Carmustine—Dizziness—Imiquimod—skin cancer	6.08e-05	0.00115	CcSEcCtD
Carmustine—Infection—Dactinomycin—skin cancer	6.06e-05	0.00114	CcSEcCtD
Carmustine—Leukopenia—Temozolomide—skin cancer	6.05e-05	0.00114	CcSEcCtD
Carmustine—Neutropenia—Docetaxel—skin cancer	6.03e-05	0.00114	CcSEcCtD
Carmustine—Thrombocytopenia—Dactinomycin—skin cancer	5.97e-05	0.00112	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Bleomycin—skin cancer	5.96e-05	0.00112	CcSEcCtD
Carmustine—Paraesthesia—Bleomycin—skin cancer	5.87e-05	0.00111	CcSEcCtD
Carmustine—Vision blurred—Fluorouracil—skin cancer	5.87e-05	0.00111	CcSEcCtD
Carmustine—Convulsion—Temozolomide—skin cancer	5.85e-05	0.0011	CcSEcCtD
Carmustine—Vomiting—Imiquimod—skin cancer	5.85e-05	0.0011	CcSEcCtD
Carmustine—Hypertension—Temozolomide—skin cancer	5.83e-05	0.0011	CcSEcCtD
Carmustine—Dyspnoea—Bleomycin—skin cancer	5.83e-05	0.0011	CcSEcCtD
Carmustine—Anorexia—Dactinomycin—skin cancer	5.81e-05	0.00109	CcSEcCtD
Carmustine—Rash—Imiquimod—skin cancer	5.8e-05	0.00109	CcSEcCtD
Carmustine—Dermatitis—Imiquimod—skin cancer	5.8e-05	0.00109	CcSEcCtD
Carmustine—Pneumonia—Docetaxel—skin cancer	5.78e-05	0.00109	CcSEcCtD
Carmustine—Headache—Imiquimod—skin cancer	5.76e-05	0.00109	CcSEcCtD
Carmustine—Anaemia—Fluorouracil—skin cancer	5.75e-05	0.00108	CcSEcCtD
Carmustine—Myalgia—Temozolomide—skin cancer	5.75e-05	0.00108	CcSEcCtD
Carmustine—Anxiety—Temozolomide—skin cancer	5.73e-05	0.00108	CcSEcCtD
Carmustine—Decreased appetite—Bleomycin—skin cancer	5.68e-05	0.00107	CcSEcCtD
Carmustine—Renal failure—Docetaxel—skin cancer	5.65e-05	0.00106	CcSEcCtD
Carmustine—Neuropathy peripheral—Docetaxel—skin cancer	5.64e-05	0.00106	CcSEcCtD
Carmustine—Stomatitis—Docetaxel—skin cancer	5.6e-05	0.00106	CcSEcCtD
Carmustine—Pain—Bleomycin—skin cancer	5.59e-05	0.00105	CcSEcCtD
Carmustine—Leukopenia—Fluorouracil—skin cancer	5.57e-05	0.00105	CcSEcCtD
Carmustine—Confusional state—Temozolomide—skin cancer	5.56e-05	0.00105	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Dactinomycin—skin cancer	5.55e-05	0.00105	CcSEcCtD
Carmustine—Oedema—Temozolomide—skin cancer	5.51e-05	0.00104	CcSEcCtD
Carmustine—Infection—Temozolomide—skin cancer	5.48e-05	0.00103	CcSEcCtD
Carmustine—Nausea—Imiquimod—skin cancer	5.47e-05	0.00103	CcSEcCtD
Carmustine—Thrombocytopenia—Temozolomide—skin cancer	5.4e-05	0.00102	CcSEcCtD
Carmustine—Convulsion—Fluorouracil—skin cancer	5.39e-05	0.00102	CcSEcCtD
Carmustine—Feeling abnormal—Bleomycin—skin cancer	5.39e-05	0.00101	CcSEcCtD
Carmustine—Chest pain—Fluorouracil—skin cancer	5.3e-05	0.000998	CcSEcCtD
Carmustine—Myalgia—Fluorouracil—skin cancer	5.3e-05	0.000998	CcSEcCtD
Carmustine—Decreased appetite—Dactinomycin—skin cancer	5.3e-05	0.000998	CcSEcCtD
Carmustine—Anorexia—Temozolomide—skin cancer	5.26e-05	0.00099	CcSEcCtD
Carmustine—Pain—Dactinomycin—skin cancer	5.21e-05	0.000982	CcSEcCtD
Carmustine—Haemoglobin—Docetaxel—skin cancer	5.19e-05	0.000977	CcSEcCtD
Carmustine—Body temperature increased—Bleomycin—skin cancer	5.17e-05	0.000973	CcSEcCtD
Carmustine—Haemorrhage—Docetaxel—skin cancer	5.16e-05	0.000972	CcSEcCtD
Carmustine—Hypoaesthesia—Docetaxel—skin cancer	5.14e-05	0.000967	CcSEcCtD
Carmustine—Confusional state—Fluorouracil—skin cancer	5.12e-05	0.000965	CcSEcCtD
Carmustine—Oedema peripheral—Docetaxel—skin cancer	5.08e-05	0.000958	CcSEcCtD
Carmustine—Oedema—Fluorouracil—skin cancer	5.08e-05	0.000957	CcSEcCtD
Carmustine—Connective tissue disorder—Docetaxel—skin cancer	5.07e-05	0.000956	CcSEcCtD
Carmustine—Infection—Fluorouracil—skin cancer	5.05e-05	0.000951	CcSEcCtD
Carmustine—Feeling abnormal—Dactinomycin—skin cancer	5.02e-05	0.000946	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Temozolomide—skin cancer	5.02e-05	0.000946	CcSEcCtD
Carmustine—Insomnia—Temozolomide—skin cancer	4.99e-05	0.00094	CcSEcCtD
Carmustine—Gastrointestinal pain—Dactinomycin—skin cancer	4.99e-05	0.000939	CcSEcCtD
Carmustine—Thrombocytopenia—Fluorouracil—skin cancer	4.97e-05	0.000937	CcSEcCtD
Carmustine—Visual impairment—Docetaxel—skin cancer	4.97e-05	0.000937	CcSEcCtD
Carmustine—Tachycardia—Fluorouracil—skin cancer	4.96e-05	0.000934	CcSEcCtD
Carmustine—Paraesthesia—Temozolomide—skin cancer	4.95e-05	0.000933	CcSEcCtD
Carmustine—Dyspnoea—Temozolomide—skin cancer	4.92e-05	0.000926	CcSEcCtD
Carmustine—Somnolence—Temozolomide—skin cancer	4.9e-05	0.000923	CcSEcCtD
Carmustine—Anorexia—Fluorouracil—skin cancer	4.84e-05	0.000912	CcSEcCtD
Carmustine—Eye disorder—Docetaxel—skin cancer	4.82e-05	0.000909	CcSEcCtD
Carmustine—Abdominal pain—Dactinomycin—skin cancer	4.82e-05	0.000908	CcSEcCtD
Carmustine—Body temperature increased—Dactinomycin—skin cancer	4.82e-05	0.000908	CcSEcCtD
Carmustine—Hypersensitivity—Bleomycin—skin cancer	4.82e-05	0.000907	CcSEcCtD
Carmustine—Decreased appetite—Temozolomide—skin cancer	4.79e-05	0.000903	CcSEcCtD
Carmustine—Flushing—Docetaxel—skin cancer	4.79e-05	0.000902	CcSEcCtD
Carmustine—Gastrointestinal disorder—Temozolomide—skin cancer	4.76e-05	0.000897	CcSEcCtD
Carmustine—Hypotension—Fluorouracil—skin cancer	4.75e-05	0.000894	CcSEcCtD
Carmustine—Constipation—Temozolomide—skin cancer	4.72e-05	0.000888	CcSEcCtD
Carmustine—Pain—Temozolomide—skin cancer	4.72e-05	0.000888	CcSEcCtD
Carmustine—Asthenia—Bleomycin—skin cancer	4.69e-05	0.000884	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Fluorouracil—skin cancer	4.63e-05	0.000872	CcSEcCtD
Carmustine—Arrhythmia—Docetaxel—skin cancer	4.61e-05	0.000869	CcSEcCtD
Carmustine—Insomnia—Fluorouracil—skin cancer	4.6e-05	0.000866	CcSEcCtD
Carmustine—Paraesthesia—Fluorouracil—skin cancer	4.56e-05	0.000859	CcSEcCtD
Carmustine—Alopecia—Docetaxel—skin cancer	4.56e-05	0.000859	CcSEcCtD
Carmustine—Feeling abnormal—Temozolomide—skin cancer	4.54e-05	0.000856	CcSEcCtD
Carmustine—Dyspnoea—Fluorouracil—skin cancer	4.53e-05	0.000853	CcSEcCtD
Carmustine—Mental disorder—Docetaxel—skin cancer	4.52e-05	0.000852	CcSEcCtD
Carmustine—Somnolence—Fluorouracil—skin cancer	4.52e-05	0.000851	CcSEcCtD
Carmustine—Gastrointestinal pain—Temozolomide—skin cancer	4.51e-05	0.000849	CcSEcCtD
Carmustine—Erythema—Docetaxel—skin cancer	4.49e-05	0.000846	CcSEcCtD
Carmustine—Malnutrition—Docetaxel—skin cancer	4.49e-05	0.000846	CcSEcCtD
Carmustine—Hypersensitivity—Dactinomycin—skin cancer	4.49e-05	0.000846	CcSEcCtD
Carmustine—Decreased appetite—Fluorouracil—skin cancer	4.42e-05	0.000832	CcSEcCtD
Carmustine—Gastrointestinal disorder—Fluorouracil—skin cancer	4.39e-05	0.000826	CcSEcCtD
Carmustine—Asthenia—Dactinomycin—skin cancer	4.37e-05	0.000824	CcSEcCtD
Carmustine—Body temperature increased—Temozolomide—skin cancer	4.36e-05	0.000821	CcSEcCtD
Carmustine—Abdominal pain—Temozolomide—skin cancer	4.36e-05	0.000821	CcSEcCtD
Carmustine—Back pain—Docetaxel—skin cancer	4.35e-05	0.000819	CcSEcCtD
Carmustine—Pain—Fluorouracil—skin cancer	4.34e-05	0.000818	CcSEcCtD
Carmustine—Feeling abnormal—Fluorouracil—skin cancer	4.19e-05	0.000789	CcSEcCtD
Carmustine—Diarrhoea—Dactinomycin—skin cancer	4.17e-05	0.000786	CcSEcCtD
Carmustine—Vomiting—Bleomycin—skin cancer	4.16e-05	0.000783	CcSEcCtD
Carmustine—Anaemia—Docetaxel—skin cancer	4.15e-05	0.000782	CcSEcCtD
Carmustine—Rash—Bleomycin—skin cancer	4.12e-05	0.000776	CcSEcCtD
Carmustine—Dermatitis—Bleomycin—skin cancer	4.12e-05	0.000776	CcSEcCtD
Carmustine—Hypersensitivity—Temozolomide—skin cancer	4.06e-05	0.000765	CcSEcCtD
Carmustine—Leukopenia—Docetaxel—skin cancer	4.02e-05	0.000758	CcSEcCtD
Carmustine—Body temperature increased—Fluorouracil—skin cancer	4.02e-05	0.000757	CcSEcCtD
Carmustine—Asthenia—Temozolomide—skin cancer	3.96e-05	0.000745	CcSEcCtD
Carmustine—Convulsion—Docetaxel—skin cancer	3.89e-05	0.000733	CcSEcCtD
Carmustine—Nausea—Bleomycin—skin cancer	3.88e-05	0.000731	CcSEcCtD
Carmustine—Hypertension—Docetaxel—skin cancer	3.88e-05	0.000731	CcSEcCtD
Carmustine—Vomiting—Dactinomycin—skin cancer	3.88e-05	0.00073	CcSEcCtD
Carmustine—Rash—Dactinomycin—skin cancer	3.84e-05	0.000724	CcSEcCtD
Carmustine—Chest pain—Docetaxel—skin cancer	3.83e-05	0.000721	CcSEcCtD
Carmustine—Myalgia—Docetaxel—skin cancer	3.83e-05	0.000721	CcSEcCtD
Carmustine—Diarrhoea—Temozolomide—skin cancer	3.77e-05	0.000711	CcSEcCtD
Carmustine—Hypersensitivity—Fluorouracil—skin cancer	3.74e-05	0.000705	CcSEcCtD
Carmustine—Confusional state—Docetaxel—skin cancer	3.7e-05	0.000697	CcSEcCtD
Carmustine—Oedema—Docetaxel—skin cancer	3.67e-05	0.000691	CcSEcCtD
Carmustine—Dizziness—Temozolomide—skin cancer	3.65e-05	0.000687	CcSEcCtD
Carmustine—Infection—Docetaxel—skin cancer	3.64e-05	0.000686	CcSEcCtD
Carmustine—Nausea—Dactinomycin—skin cancer	3.62e-05	0.000682	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—skin cancer	3.59e-05	0.000676	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—skin cancer	3.58e-05	0.000674	CcSEcCtD
Carmustine—Vomiting—Temozolomide—skin cancer	3.51e-05	0.00066	CcSEcCtD
Carmustine—Anorexia—Docetaxel—skin cancer	3.5e-05	0.000658	CcSEcCtD
Carmustine—Rash—Temozolomide—skin cancer	3.48e-05	0.000655	CcSEcCtD
Carmustine—Diarrhoea—Fluorouracil—skin cancer	3.48e-05	0.000655	CcSEcCtD
Carmustine—Dermatitis—Temozolomide—skin cancer	3.47e-05	0.000654	CcSEcCtD
Carmustine—Headache—Temozolomide—skin cancer	3.45e-05	0.000651	CcSEcCtD
Carmustine—Hypotension—Docetaxel—skin cancer	3.43e-05	0.000646	CcSEcCtD
Carmustine—Dizziness—Fluorouracil—skin cancer	3.36e-05	0.000633	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—skin cancer	3.34e-05	0.000629	CcSEcCtD
Carmustine—Insomnia—Docetaxel—skin cancer	3.32e-05	0.000625	CcSEcCtD
Carmustine—Paraesthesia—Docetaxel—skin cancer	3.29e-05	0.00062	CcSEcCtD
Carmustine—Nausea—Temozolomide—skin cancer	3.28e-05	0.000617	CcSEcCtD
Carmustine—Dyspnoea—Docetaxel—skin cancer	3.27e-05	0.000616	CcSEcCtD
Carmustine—Somnolence—Docetaxel—skin cancer	3.26e-05	0.000614	CcSEcCtD
Carmustine—Vomiting—Fluorouracil—skin cancer	3.23e-05	0.000609	CcSEcCtD
Carmustine—Rash—Fluorouracil—skin cancer	3.2e-05	0.000603	CcSEcCtD
Carmustine—Dermatitis—Fluorouracil—skin cancer	3.2e-05	0.000603	CcSEcCtD
Carmustine—Decreased appetite—Docetaxel—skin cancer	3.19e-05	0.000601	CcSEcCtD
Carmustine—Headache—Fluorouracil—skin cancer	3.18e-05	0.0006	CcSEcCtD
Carmustine—Gastrointestinal disorder—Docetaxel—skin cancer	3.17e-05	0.000596	CcSEcCtD
Carmustine—Constipation—Docetaxel—skin cancer	3.14e-05	0.000591	CcSEcCtD
Carmustine—Pain—Docetaxel—skin cancer	3.14e-05	0.000591	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—skin cancer	3.02e-05	0.000569	CcSEcCtD
Carmustine—Nausea—Fluorouracil—skin cancer	3.02e-05	0.000569	CcSEcCtD
Carmustine—Gastrointestinal pain—Docetaxel—skin cancer	3e-05	0.000565	CcSEcCtD
Carmustine—Abdominal pain—Docetaxel—skin cancer	2.9e-05	0.000546	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—skin cancer	2.9e-05	0.000546	CcSEcCtD
Carmustine—Hypersensitivity—Docetaxel—skin cancer	2.7e-05	0.000509	CcSEcCtD
Carmustine—Asthenia—Docetaxel—skin cancer	2.63e-05	0.000496	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—skin cancer	2.51e-05	0.000473	CcSEcCtD
Carmustine—Dizziness—Docetaxel—skin cancer	2.42e-05	0.000457	CcSEcCtD
Carmustine—Vomiting—Docetaxel—skin cancer	2.33e-05	0.000439	CcSEcCtD
Carmustine—Rash—Docetaxel—skin cancer	2.31e-05	0.000436	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—skin cancer	2.31e-05	0.000435	CcSEcCtD
Carmustine—Headache—Docetaxel—skin cancer	2.3e-05	0.000433	CcSEcCtD
Carmustine—Nausea—Docetaxel—skin cancer	2.18e-05	0.00041	CcSEcCtD
